Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 7, 2016; 22(33): 7569-7578
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7569
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7569
Figure 4 Cumulative incidence of hepatocellular carcinoma development after sustained virological response, shown according to AKR1B10 expression level.
- Citation: Murata A, Genda T, Ichida T, Amano N, Sato S, Tsuzura H, Sato S, Narita Y, Kanemitsu Y, Shimada Y, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S. Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication. World J Gastroenterol 2016; 22(33): 7569-7578
- URL: https://www.wjgnet.com/1007-9327/full/v22/i33/7569.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i33.7569